Free Trial

Zurcher Kantonalbank Zurich Cantonalbank Has $2.56 Million Stock Holdings in Genpact Limited (NYSE:G)

Genpact logo with Computer and Technology background

Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Genpact Limited (NYSE:G - Free Report) by 18.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,847 shares of the business services provider's stock after purchasing an additional 7,854 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Genpact were worth $2,562,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Cornerstone Planning Group LLC acquired a new position in Genpact during the 1st quarter worth $27,000. Coppell Advisory Solutions LLC boosted its position in shares of Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares in the last quarter. Atlas Capital Advisors Inc. increased its stake in Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after purchasing an additional 216 shares in the last quarter. Richardson Financial Services Inc. bought a new stake in Genpact in the 1st quarter valued at $35,000. Finally, GeoWealth Management LLC raised its position in Genpact by 199.0% in the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after buying an additional 583 shares during the last quarter. 96.03% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other Genpact news, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction dated Tuesday, May 13th. The shares were bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the purchase, the director directly owned 2,000 shares of the company's stock, valued at approximately $87,940. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 3.07% of the stock is currently owned by corporate insiders.

Genpact Trading Down 3.7%

G opened at $42.44 on Friday. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48. Genpact Limited has a 1-year low of $32.18 and a 1-year high of $56.76. The company has a fifty day moving average price of $43.97 and a two-hundred day moving average price of $47.19. The company has a market cap of $7.42 billion, a P/E ratio of 14.48, a price-to-earnings-growth ratio of 1.67 and a beta of 0.92.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The company's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.73 EPS. Analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.6%. Genpact's dividend payout ratio is currently 23.21%.

Wall Street Analyst Weigh In

Several brokerages recently commented on G. Robert W. Baird reduced their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Mizuho boosted their price objective on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a report on Tuesday, July 1st. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Deutsche Bank Aktiengesellschaft started coverage on Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 target price for the company. Finally, Needham & Company LLC reissued a "buy" rating and set a $50.00 price target on shares of Genpact in a research note on Monday, June 30th. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $49.75.

View Our Latest Research Report on Genpact

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

7 Nuclear Stocks One Announcement Away from Exploding
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines